Noriaki Hirayama Selected Research

Noriaki Hirayama Research Topics

3	Neoplasms (Cancer) 01/2020 - 04/2008
2	Rheumatoid Arthritis 01/2017 - 01/2013
2	Multiple Sclerosis 01/2017 - 01/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 01/2013
2	Disease Progression 01/2014 - 12/2012
2	Inflammation (Inflammations) 01/2014 - 04/2008
2	Thrombosis (Thrombus) 05/2010 - 04/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Intervertebral disc disease 11/2018
1	Hypersensitivity (Allergy) 06/2018
1	Infections 01/2016
1	Squamous Cell Carcinoma of Head and Neck 10/2014
1	Gliosis 01/2014
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2013
1	Carotid Artery Thrombosis 05/2010
1	Hemorrhage 05/2010
1	Pathologic Processes 04/2008
1	Fibrosis (Cirrhosis) 04/2008
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2007
1	Hypoxia (Hypoxemia) 12/2007
1	Ischemia 12/2007

3	HLA Antigens (Human Leukocyte Antigens)IBA 06/2018 - 01/2013
3	Peptides (Polypeptides)IBA 01/2017 - 01/2013
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2019
2	ferric chlorideIBA 05/2010 - 04/2008
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	C-Type Lectins (C-Type Lectin)IBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 11/2018
1	HLA-DRB1 Chains (HLA DRB1)IBA 06/2018
1	Nevirapine (Viramune)FDA Link 06/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	GalactosidasesIBA 01/2017
1	StreptavidinIBA 01/2017
1	LigandsIBA 10/2014
1	acetamideIBA 01/2014
1	WN1316IBA 01/2014
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2013
1	BilirubinIBA 01/2013
1	HLA-A Antigens (HLA-A)IBA 01/2013
1	Superoxide Dismutase-1IBA 12/2012
1	Plasminogen Activators (Plasminogen Activator)IBA 05/2010
1	5- chloro- 2- (((2- (4- (diphenylmethyl)piperazin- 1- yl)- 2- oxoethoxy)acetyl)amino)benzoateIBA 05/2010
1	Clopidogrel (Plavix)FDA Link 05/2010
1	Ticlopidine (Ticlid)FDA LinkGeneric 05/2010
1	Plasminogen InactivatorsIBA 05/2010
1	Plasminogen Activator Inhibitor 1IBA 04/2008
1	SerpinsIBA 04/2008
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 04/2008
1	Prolyl-Hydroxylase InhibitorsIBA 12/2007

2	Therapeutics 01/2019 - 01/2014
1	Oral Administration 12/2007